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MARK B. HOLLANDER, M.D.
In the 28 years since the original report on grenz rays was published a great
deal of experience with this technic has been amassed. It is surprising that,
in spite of some excellent therapeutic results which have been reported, and in
spite of the inviting nature of the theoretical considerations upon which the
modality is based, it has not been taken up to any extent by American derma-
tologists until quite recently. Very little fundamental investigative work with
it has been done in this country. Misconceptions are still rife, and the subject
remains highly controversial. Since there is ample evidence to put an under-
standing of the role of grenz rays in superficial radiotherapy on a sound basis,
it appears worth while to attempt to set forth briefly some of the pertinent data,
and thus to permit for ultimate detailed evaluation of the modality.
PHYSICAL CONSIDERATIONS
The grenz rays were described by Bucky (1) in 1923. As defined by him (2)
and accepted by others (3—30), they are x-rays of 1—4 Angstroms (A), averaging
2 A, produced in tubes whose windows will permit the emergence of such soft
rays in practical, usable amounts. The original grenz-ray tubes had windows
of Lindemann glass (1, 17), a mixture of lithium and beryllium borates. Later
ones used inverted "bubble" windows (31, 32) of pyrex glass, while today's
tubes have windows of metaffic beryllium.
These windows make the very long wavelengths available. The hardness of
the shorter wavelengths is limited by the impressed peak kilovoltage (KVP),
in accordance (26, 29) with the formula Amia = 12.354/Ky. In the original
Lindemann-window tubes, the hardest beam in the grenz-ray range was pro-
duced (2, 4, 8, 29) at from 8—12 KVP. In today's beryllium-window tubes, radia-
tion of this quality is obtained (33, 34) at about 14—15 KVP.
It must be emphasized that radiations generated at higher voltages, and of
qualities above half-value layer (HVL) 0.035 mm. Al, are not to be confused
with grenz rays. They are soft x-rays, but the difference between them and
grenz rays can be seen readily by reference to the absorption curves of EbbehØj
(15) in Figure 1. Since back-scatter is negligible (35, 26) in this range, these
curves are equivalent to depth-dose curves, and they show at a glance how
rapidly the depth-dosage increases with rise in quality. Even the step from
medium (curve 4) to hard (curve 5) grenz rays, representing an increase
from about 12 to about 14 KVP, doubles the dose at 3 mm., the maximal thick-
ness (36, 37) of normal skin. With increase in voltage beyond the grenz-ray
range, the depth-dosage climbs quickly, and effects become possible which could
not be produced by more superficial radiations. It was for that reason that
Bucky established the upper limit of the grenz-ray range at HVL 0.036 mm. Al,
and it was for that reason that, at a meeting of the Council for the Study of
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Grenz-Ray Therapy on March 17, 1950, the upper limit of the grenz-ray range
was set at HVL 0.035 mm. Al.
Grenz rays are absorbed quite strongly in air, so that they do not obey the
inverse-square law. Intensities calculated by the inverse-square law are always
higher than the observed intensities. Attention was directed to this early by
Glasser (2, 4) and Mutscheller (38). Detailed studies on air absorption have
been done recently by Day and Taylor (39) at the National Bureau of Standards
and by Jennings (40) in England. Day and Taylor, working with constant po-
tential at a minimum distance of 119 cm., found that rays generated at 7.5 KY
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Fxo. 1. Absorption curves for grenz rays and soft x-rays. After Ebbehøj, E.
were already filtered down to a homogeneous beam at that distance. Jennings's
data show that, for a 10 KVP unifitered beam, increase in focus-skin distance
(FSD) from 10 to 20 cm. reduced the intensity to 78 % of that calculated by the
inverse-square law. Similarly, air absorption caused by increase in FSD from 10
to 30 cm. reduced intensity to 65 %, while increase from 10 to 50 cm. reduced
it to 44 % of that calculated by the inverse-square law. This was in addition to
the absorption of very soft rays in the 7 cm. or so of air included in the original
10 cm. For unfiltered 20 KVP rays, air absorption reduced the intensities cor-
respondingly to 88 % at 20 cm., 78 % at 30 cm., and 61 % at 50 cm.; while for
unifitered 30 KYP rays the corresponding figures were 90 % at 20 cm., 82 % at
30 cm., and 68 % at 50 cm. These figures show the high absorption of the longer
wavelengths in air.
With today's tubes, air absorption of grenz rays thus limits practicable FSDs
to a maximum of 20-25 cm., for at greater distances the drop in intensity causes
I. HV.L. 0.011 M.M.AL.
2.HL. 0.018 M.M.AL
3.HV.L.0,022 M.M.AL
4. HL. 0.027 M.M.AL.
5. H/.L. 0.O4 M.M.AL,
6. HV.L. 0.059 M.M.AL
7.HV.L.Q.108 M.M.AL
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too great increase in treatment time. The diameters of effective treatment
fields are about of the FSD, so that the largest usable fields are about 15—18
cm. in diameter.
BIOPHYSICAL CONSIDERATIONS
Grenz rays therefore offer a means of delivering effective dosage (2, 18, 22—25,
27, 41, 42) to the skin with a minimum of danger (vide infra) to it or to the or-
gans and structures in and beneath it. These rays are absorbed relatively super-
ficially, as the curves in Figure 1 show.
Bucky postulated (2) differences in biologic action between grenz rays and
x-rays. He stated that there were differences in erythema, pigmentation, histo-
logic changes, biologic effect on the skin, and biologic effect on the total or-
ganism. This thesis was supported (43, 44) by some contemporaries, disputed
(45, 46, 47) by others. It still remains a moot point, though some recent bio-
physical work has indicated a wavelength dependence of biologic effect. Spear
(48) and Catcheside and Lea (49) used chromosome-breaks in pollen grains of
Tradescantia bracteata as a biologic indicator to show the amount of ionization
required to produce breaks. Lea (50) made detailed calculations showing that
the average ion density of secondary electrons is almost constant for rays pro-
duced at from 30 to 180 KV. Gray (51) determined the mean linear ion density
for the range from 1000 to 3 KV, and Catcheside and Lea (49) showed that the
coefficient of chromosome-breakage in their experiments was highest at 4.1 A,
falling off through 1.5 A to 0.15 A. In the light of this work, it appears that
the low energy of grenz-ray photoelectrons may produce effects differing, at
least in degree, from those of higher energy x-ray secondary electrons.
RANGE OF ThERAPEUTIC EFFECTIVENESS
Low depth doses limit or block the effectiveness of grenz rays in the treatment
of many deep dermatoses. Tinea capitis, cystic acne (53, 22, 24), the tumor
stage (52, 53, 18, 22, 27) of mycosis fungoides, and epithelioma of more than
1—2 mm. in depth (54, 55) call for more penetrating radiation. However, Sagher
has reported (56, 57) surprising results from experimental irradiation of leproma-
tons infiltrates, and regards grenz rays as the treatment of choice (58, 59) in
cutaneous leishmaniasis.
This limitation becomes an asset in the treatment of superficial dermatoses,
making possible the use of high surface dosage with little fear of the consequences
of high depth-dosage. Even such chronic recurrent dermatoses as psoriasis
(60, 20, 23), neurodermatitis (61, 62, 63), and some types of localized pruritus
(64, 10, 65) can be treated safely and with repeated courses, without great con-
cern for the sequelae which the cumulative effects of more penetrating radia-
tions in excessive aggregate dosage might produce.
SEQUELAR
As ionizing radiations, grenz rays can cause injury to the skin, though only
superficial damage has been reported following their use. Superficial atrophy
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arid telangiectasia may occur (8, 12, 22, 56, 66—71) after either very large doses of
soft rays (HVL 0.016—0.022 mm. Al) or smaller doses of hard rays (HVL 0.030—
0.035 mm. Al). The dose which is required (8, 66, 67, 68, 12, 72, 29) to accom-
plish such damage, though, is far beyond the range of the usual therapeutic
doses. Sequelae have been reported resulting from larger doses, i.e. thousands
of r rather than from smaller doses, i.e. hundreds of r. The first two cases of su-
perficial atrophy and telangiectasia were reported by Bucky (2, PP. 97, 98),
and most workers with the technic have seen such injuries.
Erythema is frequently produced by intensive grenz ray therapy, but is not
a contraindication to further treatment. It appears earlier (22, 73—78) than does
x-ray erythema, usually lasts (75, 76, 22) from a few days up to four weeks,
and, like x-ray erythema, may show (2, 76, 79, 14, 78, 22) the wave-like fluctua-
tions in intensity described (80) by Miescher. When erythema has occurred,
treatment can be resumed when necessary after the erythem has subsided.
There has been much discussion about the "erythema dose" of grenz rays. It
appears impossible to set a figure here, because of the marked variation in
response with quality. The range is about 250—400 r. In any individual, it will
require (81, 76, 79, 82, 78, 18) a smaller dose of hard than of soft grenz rays to
produce an erythema. It appears preferable (83, 73, 76) to avoid the concept
entirely, and to discuss grenz ray dosage only in terms of roentgens and quality
until a biologic indicator independent of wavelength is devised.
This paradox in the biologic action of grenz rays, in that the erythema dose
of hard rays is smaller than that of soft rays, is probably explainable on the
basis that the hard beam contains a greater percentage of rays capable of reach-
ing and affecting the superficial vascular plexus.
Pigmentation occurs more frequently following grenz rays administered in
routine dosage, and is usually somewhat more intense (84) than that produced by
x-rays or ultraviolet radiation. Most of the pigmentation produced with ordinary
dosage disappears within the first few weeks after termination of therapy.
However, striking differences exist between the sequelae of overdosage of
grenz rays and those produced by overdosage of x-rays. For the hardest of the
grenz rays (Figure 1, curve * 5), the dose at 3 mm. depth is 7 % of the dose in
air at the surface. To deliver an epilating dose of 350 r to the hair bulbs would
thus require a surface dose of 5000 r. In actual experience, even temporary
epilation in the human has been reported (85, 86) only twice, to the author's
knowledge, and many observers (6, 8, 87, 88, 72, 22, 27, 29) have called atten-
tion to the safety of the hair, including the eye lashes, under grenz-ray therapy.
Though superficial atrophy and telangiectasia are seen, records of instances of
sclerosis, permanent dryness, permanent epilation, wrinkling, and other se-
quelae of intermediate depth have not been found. Of perhaps far greater im-
portance, though, is the fact that a review (104) of the world literature on
grenz rays, done recently by Sagher of Jerusalem and the author, failed to
locate any report of a keratosis, indolent ulcer, or epithelioma resultant upon
the use of these rays. This confirms the findings of other (18, 19, 20, 24, 27, 29),
earlier reviews.
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TABLE 1
GRZNZ RAYS
Wavelengths 1—4 A, averaging 2 A. Voltage
range 6—15 KVP. HVL 0.012 mm. to 0.035
mm. Al. Soft rays up to HVL 0.020-0.022
mm. Al (curves 2, 3). Medium rays HVL
0.022—0.028 mm. Al (curves 3, 4). Hard
rays HVL 0.030-0.035 mm. Al (curve 5)
Air absorption very high, thus limiting
greater and more practicable FSDS*. With
today's tubes, FSD limited to maximum
of about 20-25 cm.
Field diameters up to 15—19 cm.
Absorbed almost completely in first 3mm. of
tissue. Back-scatter not yet detected, may
be non-existent. Depth-dose falls off
rapidly, is insignificant beyond 3 mm.
Exit dose negligible on ears, digits, palms,
and nose. Virtually non-existent elsewhere
Erythema occurs not infrequently, does not
contraindicate further treatment. May
show wave-like fluctuations of Mieseher
Superficial atrophy and telangiectasia occur
infrequently, only after very high dosage.
Deeper sequelae not reported. No record
of keratosis, ulcer, epithelioma, or leuke-
mia found
Can be used safely over radiosensitive deep
organs. No apparent danger of cataract,
sterilization, or inhibition of bony growth
centers
x-RAYS
Wavelengths 0.12—1 A. Voltage range from
15—20 KVP up, conventionally 50—100
KVP for dermatologists. HVL 0.050 mm.
to 1 mm. Al (inherent filter only)
Air absorption negligible, with conventional
tubes. Quite high for unfiltered beams
from beryllium-window tubes. FSD up to
50 cm. practicable
Field diameter about 75% of FSD, for
shock-proof units
Penetrating power rises rapidly with volt-
age. Back-scatter increases with voltage,
with increase in area of field, and with
increase in volume of tissue, adding still
more to depth-dose
Exit dose quite appreciable, especially
above 60 KYP. Must be taken into con-
sideration in thin areas
Erythema, when produced, usually contra-
indicates further treatment in benign
disease. Shows Miescher's waves
Sequelae of any depth or degree may be
produced, if large enough doses are given.
May range in severity up to metastasiz-
ing carcinoma. Leukemia is a hazard to
the operator if necessary precautions are
not taken
When given in large doses, radiosensitive
deep organs in danger. Sterilization, cat-
aract and inhibition of bony growth cen-
ters in children can be produced by ex-
cessive dosage
* Focus—skin distance.
Radiosensitive deep organs and structures, such as the eye, the testes, and the
bony growth centers of children, seem to be safe from the grenz rays (8, 87, 89,
72, 22, 27, 29) because of the low depth doses. This has been emphasized par-
Erythema dose varies widely with quality. Erythema dose usually critical. Greater for
Smaller for hard rays than for soft hard rays than for soft
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ticularly in the treatment of such conditions as epithelioma of the lids, pruritus
scroti, and dermatoses (90, 87, 91) in children.
Protection, in the conventional sense, is not needed for patient, operator, or
workers in adjacent rooms. Absorption of grenz rays in air is so great that ade-
quate distance protects the operator, and lack of scatter in the grenz ray range
protects everything outside of the direct beam.
For ready reference, the major differences between grenz rays and x-rays are
listed in Table 1.
COMMENT
A perusal of the literature will show that there has always been a remark-
able amount of controversy about grenz rays. Historically, this may have been
a projection of the much earlier misconception (2, pp. 2—5) about "dangerous
soft" and "ineffective hard" x-rays, ultimately shown to be a question of dosage
rather than a quality effect.
When Bucky reported his early experiences with the grenz ray portion of the
roentgen spectrum, a controversy arose concerning his over-enthusiastic state-
ment that only a small, harmless percentage of grenz rays reached the basal
layer of human skin and his claim that grenz rays were different from x-rays.
Martenstein (92) ingeniously showed that recognizable radiographs of guinea-
pig chests could be made with grenz rays, and claimed that his experiment
proved that grenz rays were no different from other x-rays. It should be men-
tioned that only a fraction of a roentgen ray was required to expose a dental
x-ray film. The work of Day and Taylor (39) shows that the minimum wave-
lengths of grenz rays penetrate at least 120 cm. of air. Some absorption work
(93, 94) was also adduced to prove that penetration into the cutis did occur.
The dispute was furthered by a set of erroneous absorption curves for 30, 60,
and 100 KY x-rays, and by the inferences drawn from them, in Bucky's book
(2, pp. 59, 16—19). These curves, calculated erroneously from Compton's tables,
demonstrate the inherent pitfalls of inductive reasoning in comparison with the
experimental method. Corrected curves for 100 and 25 KY have since been
published (95) by Bucky.
Another, and perhaps more serious, disagreement arose over Bucky's equally
over-enthusiastic claim (2, p. 111) that radiation sequelae were not produced by
grenz rays. To a man accustomed to the post-irradiation catastrophes of 1897—
1915, the superficial late effects of grenz ray overdosage probably did not de-
serve to be called sequelae. However, the statement was taken literally, and
American dermatologists, apparently forgetting that Bucky himself had reported
(2, pp. 97—98) the first two cases of atrophy and telangiectasis caused by grenz
rays, demonstrated several cases (96—100) themselves, and apparently con-
cluded that this discredited the technic.
These controversies are quite understandable in perspective. MacKee's funda-
mental work had only recently placed radiotherapy of the skin on a sound, safe
basis, and the physical measurement of x-ray dosage was just beginning. Actual
measurement of depth-dosage was new, and the international r, proposed in
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1927, was not accepted officially as the unit of x-ray dosage (103) until 1937.
Also, hyperbole is ever vulnerable to the danger of being taken literally. It is
scarcely surprising that Bucky's emphatic claims aroused opposition among his
contemporaries.
It is a little more difficult to assess the misconceptions and misunderstandings
which still persist concerning grenz rays. It appears probable that the early
controversies blocked objective evaluation of the technic by the teachers of
the day. Today, most of the medical men in this country who have heard of the
modality at all know it only as a technic which is impracticable and useless.
Errors and misconceptions are still being perpetuated.
In his evaluation of grenz rays (8) for the Council on Physical Medicine of
the AMA in 1931, MacKee said, "In general, it is doubtful whether any skin
disease. . . can be cured with grenz rays that cannot be cured with x-rays of
shorter wavelengths or with beta rays of radium." This statement has been re-
peated many times and in many places, most recently in the last edition (29)
of his book.
So far as can be ascertained, the statement is entirely true; it also seems to be
beside the point. Except for nevus fiammeus, keratosis follicularis, and a few
other uncommon dermatoses, no record or claim had been found concerning
skin diseases which could be treated effectively with grenz rays, but not with
x-rays or beta rays. How to evaluate this fact is somewhat of a problem, for the
rationale of therapy with the long wavelengths is not based on increased range
of effectiveness, but on safety. All that seems really to matter is that grenz rays
provide equal therapeutic effectiveness with substantial increase in safety. It
is difficult to see the validity of any other comparison.
In March, 1950, there was presented (105) before a dermatological society
meeting a case of "Dermatitis Due to Grenz Rays." The patient had been
working, at a distance of 45 cm., with unfiltered 25 KY radiations from a beryl-
lium-window tube. He was represented as having been hypersensitive to the
sun's rays since early childhood. One discussant stated: ". . . the beam of grenz
rays. . . is the same as that of x-rays and produces the same type of damage."
Another said, "One of the strong contentions of the proponents of grenz ray
therapy is that these rays do no harm."
It appears important to correct such misconceptions. Since the upper limit of
the grenz-ray range does not extend above 14—15 KVP, this radiodermatitis was
not produced by grenz rays, but by soft x-rays. It is evident, as previously men-
tioned, that the softer components of the 25 KV beam, i.e., the grenz rays would
have been filtered out by the air at 45 cm.
The world experience shows that the damage resultant upon overdosage with
grenz rays does not approach in magnitude or severity that which may follow
overdosage with x-rays of conventional wavelengths. As exemplified by Bucky's
original report of atrophy and telangiectasia, the proponents of grenz ray ther-
apy do not contend that these rays can do no harm. They accept the fact that
any agent potent enough to do good is also potent enough to do harm, and
recognize the great advantage of grenz rays to reside in the fact that they can
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be used, not with complete safety, but with safety far greater than that af-
forded by x-rays of conventional quality.
CONCLUSIONS
1. Grenz rays are x-rays of 1-4 A, produced in thin-windowed tubes at 6—
15 KYP.
2. They are absorbed strongly in air, and are absorbed almost completely in
the first 3 mm. of tissue.
3. Their margin of safety is greater than that of conventional x-rays.
4. They are inadequate for the treatment of disease at depths of more than
2 to 3 mm.
5. They are capable of causing superficial damage to the skin, but are not
yet reported to have caused an instance of keratosis, chronic ulcer, or epithe-
lioma.
6. The modality is in need of further detailed evaluation.
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